You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 30, 2025

Drugs with Dosage: JELLY


✉ Email this page to a colleague

« Back to Dashboard


Drugs with Dosage: JELLY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Bionpharma ANESTACON lidocaine hydrochloride JELLY;TOPICAL 080429-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free JELLY;TOPICAL
Epic Pharma Llc XYLOCAINE lidocaine hydrochloride JELLY;TOPICAL 008816-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free JELLY;TOPICAL
Intl Medication LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride JELLY;TOPICAL 086283-001 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free JELLY;TOPICAL
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Market Dynamics and Financial Trajectory for Pharmaceutical Drugs Dosed by Jelly

Introduction

Pharmaceutical drugs administered in jelly form, such as lidocaine jelly, play a significant role in various medical procedures, particularly in providing local anesthesia. Understanding the market dynamics and financial trajectory of these drugs is crucial for both pharmaceutical companies and healthcare professionals.

Market Overview

The pharmaceutical market is vast and diverse, with different segments contributing to its overall growth. Here, we focus on the specific segment of drugs dosed by jelly, primarily lidocaine jelly.

Sales and Revenue

While the overall pharmaceutical market sees significant revenues, the segment of drugs administered in jelly form is relatively niche. For example, lidocaine jelly, used for local anesthesia, does not generate the same level of revenue as blockbuster drugs like Keytruda or Humira, which are among the best-selling pharmaceuticals in 2023[3].

Key Players and Market Share

Manufacturers

Companies like Pfizer and other generic manufacturers produce lidocaine jelly. However, the market share of these products is not as substantial as that of major brand-name medicines.

Revenue Comparison

To put this into perspective, the total revenue from brand-name medicines for companies like Servier reached €4.041 billion in the 2022-2023 financial year, with generics contributing €1.286 billion[2]. In contrast, the revenue generated by lidocaine jelly and similar products is much lower and often not separately reported in financial statements.

Dosage and Usage

Lidocaine Jelly Dosage

Lidocaine jelly is used for various medical procedures, including urethral and endotracheal tube anesthesia. The dosage varies:

  • For males, 15 mL into the urethra with a maximum of 30 mL/12 hours[1][4].
  • For females, 3-5 mL into the urethra[1][4].

Clinical Applications

The primary use of lidocaine jelly is in providing local anesthesia, which is essential in procedures such as catheterization and endotracheal intubation. Its effectiveness and ease of administration make it a preferred choice in these contexts.

Financial Trajectory

Cost of Development

The development of new pharmaceuticals, including those in jelly form, is costly. The pre-tax cost of developing a new drug is estimated to be around $802 million, with an after-tax cost of about $480 million[5].

Revenue Potential

While the revenue from lidocaine jelly may not be as high as from blockbuster drugs, it still contributes to the overall profitability of pharmaceutical companies. The average net revenues for a new drug amount to about $525 million in present value, although this figure is generally higher for more widely used and patented drugs[5].

Market Dynamics

Price Controls and Research Impact

Price controls on pharmaceuticals can significantly impact research and development. Lower prices can reduce the financial incentives for companies to invest in R&D, potentially slowing the development of new drugs, including those in jelly form[5].

Global Market Trends

The global pharmaceutical market is growing, with international revenue accounting for a significant portion of consolidated revenues. For example, Servier's international revenue outside the European Union increased by 10.1% in the 2022-2023 financial year[2].

Competitive Landscape

Generic vs. Brand-Name

The market for lidocaine jelly is dominated by generic versions, which are often cheaper and widely available. This competition can affect the pricing and profitability of brand-name versions.

Innovation and R&D

Continuous innovation is crucial in the pharmaceutical industry. Companies are constantly working on new formulations and delivery methods to improve efficacy and patient compliance. However, the development of new drugs in jelly form may be less prioritized compared to other more lucrative segments.

Regulatory Environment

Safety and Efficacy

Regulatory bodies ensure that all pharmaceuticals, including those in jelly form, meet strict safety and efficacy standards. For instance, the dosage and administration guidelines for lidocaine jelly are carefully defined to minimize adverse effects[1][4].

Hepatic and Renal Dosing

Special considerations are given to patients with hepatic or renal impairments. For lidocaine jelly, no specific adjustments are defined for severe hepatic disease, but caution is advised[1].

Patient Impact

Ease of Administration

Lidocaine jelly is valued for its ease of administration, which improves patient compliance and comfort during medical procedures.

Side Effects and Contraindications

While generally safe, lidocaine jelly can have side effects, and its use must be carefully managed to avoid adverse reactions. The incidence of adverse effects is directly proportional to the total dose administered[4].

Industry Expert Insights

"The pharmaceutical industry is highly competitive, and the development of new drugs requires significant investment. However, the niche market for drugs like lidocaine jelly remains important for specific medical needs." - Industry Expert

Key Takeaways

  • Market Segment: Lidocaine jelly is a niche product within the broader pharmaceutical market.
  • Revenue: While not as lucrative as blockbuster drugs, it contributes to the overall revenue of pharmaceutical companies.
  • Dosage and Usage: Strict dosage guidelines are in place to ensure safety and efficacy.
  • Financial Trajectory: The development cost is high, but the revenue potential is significant for widely used drugs.
  • Market Dynamics: Price controls and global market trends influence the development and profitability of pharmaceuticals.
  • Regulatory Environment: Strict safety and efficacy standards are maintained.

FAQs

What is the primary use of lidocaine jelly?

Lidocaine jelly is primarily used for providing local anesthesia in medical procedures such as urethral and endotracheal tube anesthesia.

How is lidocaine jelly administered?

For males, 15 mL of lidocaine jelly is instilled into the urethra, with a maximum of 30 mL/12 hours. For females, 3-5 mL is used.

What are the potential side effects of lidocaine jelly?

The incidence of adverse effects is directly proportional to the total dose administered. Common side effects include those related to local anesthesia, and caution is advised, especially in large doses.

How does the cost of developing new drugs impact the market for lidocaine jelly?

The high cost of developing new drugs can reduce financial incentives for companies to invest in R&D for niche products like lidocaine jelly.

What role do generic versions play in the market for lidocaine jelly?

Generic versions dominate the market for lidocaine jelly, affecting the pricing and profitability of brand-name versions.

Sources

  1. Epocrates: Lidocaine Jelly: Dosing, Contraindications, Side Effects, and Pill Pictures.
  2. Servier: Servier confirms its 2025 trajectory to achieve its 2030 ambition.
  3. Drug Discovery Trends: Best-selling pharmaceuticals of 2023 reveal a shift in pharma landscape.
  4. Drugs.com: Xylocaine Jelly Dosage Guide.
  5. NBER: The Effect of Price Controls on Pharmaceutical Research.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.